Bing Lu Selected Research

serine-pyruvate aminotransferase

11/2019

Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Lu Research Topics

Disease

39	Neoplasms (Cancer) 06/2022 - 08/2003
25	Rheumatoid Arthritis 03/2022 - 01/2009
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2004
14	Inflammation (Inflammations) 09/2022 - 09/2008
10	Infections 01/2022 - 09/2013
10	Osteoarthritis 05/2020 - 12/2011
9	Pain (Aches) 01/2022 - 01/2009
6	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2010
5	Cataract (Cataracts) 03/2022 - 01/2020
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 02/2005
5	Knee Osteoarthritis 05/2019 - 12/2014
4	Choroidal Neovascularization 05/2022 - 01/2016
4	Hypertension (High Blood Pressure) 03/2022 - 09/2008
4	Wounds and Injuries (Trauma) 01/2022 - 01/2014
4	Human Influenza (Influenza) 04/2021 - 04/2014
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2017
4	Coronary Disease (Coronary Heart Disease) 01/2020 - 09/2008
3	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 01/2016
3	Cicatrix (Scar) 01/2022 - 06/2006
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 01/2018
3	Thrombosis (Thrombus) 10/2021 - 08/2010
3	Asthma (Bronchial Asthma) 01/2021 - 05/2016
3	Diabetes Mellitus 08/2014 - 09/2008
3	Rheumatic Diseases (Rheumatism) 01/2014 - 12/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2011 - 06/2011
3	Lupus Nephritis 12/2011 - 06/2011
2	Carcinoma (Carcinomatosis) 01/2022 - 11/2005
2	Carcinogenesis 01/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2022 - 04/2016
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 08/2003
2	HIV Infections (HIV Infection) 01/2022 - 10/2018
2	Fibrosis (Cirrhosis) 01/2022 - 01/2017
2	COVID-19 04/2021 - 10/2020
2	Rheumatoid Nodule 01/2021 - 01/2019
2	Radiation Pneumonitis 01/2021 - 11/2020
2	Disease Progression 01/2021 - 01/2018
2	Diarrhea 01/2020 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 08/2010

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2008
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2010
9	C-Reactive ProteinIBA 01/2021 - 02/2005
8	Pharmaceutical PreparationsIBA 06/2022 - 12/2010
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2016
6	CytokinesIBA 01/2022 - 04/2019
6	Biological ProductsIBA 11/2021 - 04/2009
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2010
5	AerosolsIBA 01/2022 - 11/2018
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2004
4	LipidsIBA 09/2022 - 08/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 09/2008
4	Long Noncoding RNAIBA 01/2022 - 03/2020
4	VaccinesIBA 01/2022 - 01/2020
4	Peptides (Polypeptides)IBA 01/2022 - 01/2019
4	AutoantibodiesIBA 07/2020 - 01/2018
4	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 04/2003
3	Particulate MatterIBA 09/2022 - 01/2020
3	Histones (Histone)IBA 06/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 06/2022 - 03/2020
3	pillar(5)areneIBA 01/2022 - 01/2022
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2022
3	ErbB Receptors (EGF Receptor)IBA 11/2021 - 08/2003
3	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 12/2010
3	AntibodiesIBA 01/2021 - 12/2010
3	Antirheumatic Agents (DMARD)IBA 01/2021 - 03/2013
3	Hemoglobins (Hemoglobin)IBA 01/2019 - 06/2011
3	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2014
3	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 04/2009
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2014 - 12/2010
2	Retinaldehyde (Retinal)IBA 09/2022 - 01/2017
2	oxidized low density lipoproteinIBA 03/2022 - 11/2011
2	LDL CholesterolIBA 03/2022 - 05/2015
2	Glucose OxidaseIBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	ProdrugsIBA 01/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 11/2019
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 08/2018
2	GS-CA1IBA 01/2022 - 01/2019
2	AcidsIBA 01/2022 - 10/2015
2	Air Pollutants (Pollutants, Air)IBA 12/2021 - 01/2020
2	Tobacco Smoke Pollution (Passive Smoking)IBA 12/2021 - 11/2019
2	Gefitinib (Iressa)FDA Link 11/2021 - 08/2003
2	ChemokinesIBA 11/2021 - 07/2020
2	Tyrosine Kinase InhibitorsIBA 11/2021 - 08/2003
2	Lysine (L-Lysine)FDA Link 10/2021 - 01/2020
2	GlucocorticoidsIBA 01/2021 - 01/2019
2	Insulin (Novolin)FDA Link 01/2021 - 06/2012
2	MicroRNAs (MicroRNA)IBA 03/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2017
2	GSK-J4IBA 01/2020 - 01/2020
2	cyclic citrullinated peptideIBA 12/2019 - 12/2010
2	Complementary DNA (cDNA)IBA 11/2019 - 01/2012

Therapy/Procedure

34	Therapeutics 06/2022 - 01/2009
17	Radiotherapy 01/2022 - 10/2013
15	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
3	Kidney Transplantation 12/2011 - 06/2011
2	Lasers (Laser) 06/2022 - 01/2021
2	Photochemotherapy (Photodynamic Therapy) 01/2022 - 11/2021
2	Mediterranean Diet 01/2021 - 05/2015